Johnson & Johnson
JNJJNJ · Stock Price
Historical price data
Overview
Johnson & Johnson is a diversified healthcare leader with a mission to prevent, treat, and cure complex diseases through smarter, less invasive, and more personalized solutions. Its strategic pivot to a pure-play Innovative Medicine and MedTech structure enhances focus and capital allocation towards high-margin, innovative therapies and advanced technologies. The company sustains its leadership through a formidable R&D engine, a robust commercial portfolio featuring multiple blockbuster drugs, and a disciplined strategy of strategic business development and portfolio optimization.
Technology Platform
A multi-modal ecosystem integrating small molecule chemistry, advanced biologics & immuno-oncology, cell & gene therapy, precision medicine biomarkers, and digital surgery/health technologies to drive innovation across pharmaceuticals and medical devices.
Pipeline
200| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Dapoxetine | Sexual Dysfunction | Phase 3 | |
| paliperidone palmitate | Schizophrenia | Phase 3 | |
| Topiramate + Placebo | Bipolar Disorder | Phase 3 | |
| topiramate | Obesity | Phase 3 | |
| JNJ-90301900 (NBTXR3) + Cetuximab | Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 3 |
FDA Approved Drugs
5
Company Timeline
Founded in New Brunswick, United States
FDA Approval: CIDA-STAT
FDA Approval: CHG SCRUB
FDA Approval: OXYGEN, USP